iBio, Inc. (IBIO): Price and Financial Metrics

iBio, Inc. (IBIO): $0.28

0.01 (+2.21%)

POWR Rating

Component Grades













Add IBIO to Watchlist
Sign Up

Industry: Biotech



in industry

IBIO Stock Summary

  • IBIO INC's market capitalization of $57,813,890 is ahead of just 13.66% of US-listed equities.
  • The capital turnover (annual revenue relative to shareholder's equity) for IBIO is 0.04 -- better than only 10.03% of US stocks.
  • With a price/sales ratio of 20.55, IBIO INC has a higher such ratio than 93.63% of stocks in our set.
  • Stocks that are quantitatively similar to IBIO, based on their financial statements, market capitalization, and price volatility, are SCWX, BASE, CTSO, ATEN, and VTEX.
  • Visit IBIO's SEC page to see the company's official filings. To visit the company's web site, go to www.ibioinc.com.

IBIO Valuation Summary

  • In comparison to the median Healthcare stock, IBIO's price/sales ratio is 309.43% higher, now standing at 21.7.
  • Over the past 156 months, IBIO's price/sales ratio has gone down 11.2.

Below are key valuation metrics over time for IBIO.

Stock Date P/S P/B P/E EV/EBIT
IBIO 2022-09-01 21.7 0.8 -1.8 -1.6
IBIO 2022-08-31 21.5 0.8 -1.8 -1.5
IBIO 2022-08-30 21.9 0.8 -1.8 -1.6
IBIO 2022-08-29 21.9 0.8 -1.8 -1.6
IBIO 2022-08-26 23.0 0.8 -1.9 -1.7
IBIO 2022-08-25 24.8 0.9 -2.1 -1.8

IBIO Growth Metrics

    Its 3 year price growth rate is now at -69.32%.
  • Its 4 year net income to common stockholders growth rate is now at -255.94%.
  • Its 4 year price growth rate is now at -70.97%.
IBIO's revenue has moved up $482,000 over the prior 15 months.

The table below shows IBIO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-03-31 2.813 -33.203 -33.286
2021-12-31 1.635 -34.608 -28.621
2021-09-30 2.172 -32.341 -24.873
2021-06-30 2.371 -30.064 -23.467
2021-03-31 3 -26.705 -27.121
2020-12-31 2.331 -23.142 -24.137

IBIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IBIO has a Quality Grade of D, ranking ahead of 5.38% of graded US stocks.
  • IBIO's asset turnover comes in at 0.017 -- ranking 375th of 681 Pharmaceutical Products stocks.
  • COLL, COCP, and IRWD are the stocks whose asset turnover ratios are most correlated with IBIO.

The table below shows IBIO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.017 0.383 -0.256
2021-03-31 0.024 0.836 -0.331
2020-12-31 0.023 1.000 -0.317
2020-09-30 0.027 1.000 -0.273
2020-06-30 0.032 1.000 -0.231
2020-03-31 0.036 1.000 -0.271

IBIO Stock Price Chart Interactive Chart >

Price chart for IBIO

IBIO Price/Volume Stats

Current price $0.28 52-week high $1.24
Prev. close $0.27 52-week low $0.22
Day low $0.28 Volume 58,776
Day high $0.28 Avg. volume 2,308,996
50-day MA $0.26 Dividend yield N/A
200-day MA $0.38 Market Cap 60.43M

iBio, Inc. (IBIO) Company Bio

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.

IBIO Latest News Stream

Event/Time News Detail
Loading, please wait...

IBIO Latest Social Stream

Loading social stream, please wait...

View Full IBIO Social Stream

Latest IBIO News From Around the Web

Below are the latest news stories about IBIO INC that investors may wish to consider to help them evaluate IBIO as an investment opportunity.

iBio shareholders approve 1-for-25 reverse stock split (IBIO)

iBio (IBIO) shareholders have approved the company''s proposal to provide for a 1-for-25 share reverse stock split.Shares are up 7% in Wednesday morning trading.However, an SEC filing…

Seeking Alpha | July 6, 2022

Is the iBio Inc. (AMEX:IBIO) stock an investment opportunity?

iBio Inc. (IBIO)’s stock is trading at $0.28 at the moment marking a fall of -0.49% from the last session close. As of this writing, shares are priced at -82.54% less than their 52-week high of $1.63, and 28.78% over their 52-week low of $0.22. Based on the past 30-day period, the stock price is … Is the iBio Inc. (AMEX:IBIO) stock an investment opportunity? Read More »

US Post News | June 17, 2022

iBio Inc. (AMEX:IBIO) Shares Rebounded 24.14% From Their Lows – But Can They Continue?

In last trading session, iBio Inc. (AMEX:IBIO) saw 1.67 million shares changing hands with its beta currently measuring -4.65. Company’s recent per share price level of $0.29 trading at $0.03 or 8.98% at ring of the bell on the day assigns it a market valuation of $55.62M. That closing price of IBIO’s stock is at … iBio Inc. (AMEX:IBIO) Shares Rebounded 24.14% From Their Lows – But Can They Continue? Read More »

Marketing Sentinel | June 9, 2022

iBio Inc. (AMEX: IBIO) Has Yet To Win Over Analysts?

iBio Inc. (AMEX:IBIO) traded at $0.26 at last check on Tuesday, June 07, made an upward move of 7.22% on its previous day’s price. Looking at the stock we see that its previous close was $0.24 and the beta (5Y monthly) reads -5.38 with the day’s price range being $0.24 – $0.27. In terms of … iBio Inc. (AMEX: IBIO) Has Yet To Win Over Analysts? Read More »

Stocks Register | June 7, 2022

iBio to Participate in the H.C. Wainwright Global Investment Conference

BRYAN, Texas, May 18, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming® Manufacturing System, today announced that it will participate virtually in the H.C. Wainwright Global Investment Conference. The hybrid conference will take place May 23-26, 2022. iBio's pre-recorded presentation will be available on demand during the event for all registered attendees. Begin

Yahoo | May 18, 2022

Read More 'IBIO' Stories Here

IBIO Price Returns

1-mo 14.29%
3-mo 1.74%
6-mo -20.90%
1-year -76.07%
3-year -55.06%
5-year -90.34%
YTD -49.00%
2021 -47.71%
2020 321.69%
2019 -66.80%
2018 -57.63%
2017 -55.75%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0676 seconds.